楚天科技 (300358)

TRUKING TECHNOLOGY LIMITED

ASZ

K-Line Chart

No K-line data available

Company NameChutian Technology Co., Ltd.
Listing Date2014-01-21
Issue Price40RMB
Registered Capital71509.25810k RMB
Legal RepresentativeTang Yue
Registered AddressNo. 1 Xinkang Road, Yutan Town, Ningxiang City, Changsha, Hunan Province
IndustryMedical Devices
Main BusinessResearch, design, production, sales, and service of liquid pharmaceutical equipment.
Company ProfileChutian Technology Co., Ltd. was founded in 2000 and has become one of the major enterprises in the global pharmaceutical equipment industry. Its main business is pharmaceutical equipment and integrated solutions, and it is a pioneer in promoting the research and development of smart pharmaceutical factories. The company is listed on China's A-share market. It has several wholly-owned or controlled subsidiaries, including Chutian Huatong, Sichuan Pharmaceutical Design Institute, Chutian Feiyun, and Chutian Intelligent Robot, with a total of over 2,900 employees (including subsidiaries) and total assets of 4 billion yuan. In 2017, Chutian Technology, together with its controlling shareholder Chutian Investment, spent over 1.1 billion yuan to acquire the world-renowned pharmaceutical equipment company German ROMACO Group. The company currently has its operational headquarters in Changsha and is preparing to establish a German operational headquarters. Upon completion, there will be three major R&D institutions: the German Technology Research Institute, the Changsha Central Technology Research Institute, and the Shanghai Technology Research Institute. It has established multiple technology and innovation platforms, including a National Enterprise Technology Center, a National Innovation Base, a Postdoctoral Research Workstation, and an Academician Expert Workstation. As of December 31, 2019, the company has filed 3,124 Chinese patent applications, with 1,831 patents granted. Additionally, it has filed 26 PCT international patent applications and obtained 15 patent grants in the United States, Japan, Russia, India, and South Korea.

Stock Details

1. Key Indicators

  • Total Shares(W): 71509.26
  • Circulating A-Shares(W): 70130.04
  • Earnings Per Share(RMB): 0.1431
  • Net Assets Per Share(RMB): 7.3597
  • Operating Revenue(W RMB): 389617.75
  • Total Profit(W RMB): 4492.03
  • Net Profit Attributable to Parent(W RMB): 8446.35
  • Net Profit Growth Rate(%): 145.11
  • Weighted Return on Equity(%): 2.0200
  • Operating Cash Flow Per Share(RMB): 0.2510
  • Undistributed Profit Per Share(RMB): 2.7580
  • Capital Reserve Per Share(RMB): 3.0861

2. Main Business

The main business covers:

  • Pharmaceutical Water
  • Bioengineering (including stainless steel and single-use integrated solutions)
  • Sterile Formulation
  • Solid Formulation
  • Inspection and Packaging
  • Traditional Chinese Medicine Formulation
  • Intelligence and Informatization
  • EPCMV Services

3. Company Basic Information

  • Company Name: Truking Technology Limited
  • Listing Date: 2014-01-21
  • Industry: Special Purpose Equipment Manufacturing
  • Address: No.1 Xinkang Road, Yutan Town, Ningxiang City, Changsha City, Hunan Province
  • Website: www.truking.cn
  • Company Profile: The Company was established by the overall change of Changsha Truking Technology Co., Ltd. into a joint stock limited company. Changsha Truking Technology Co., Ltd. converted its audited net assets of RMB 145,746,802.21 as of September 30, 2010 into 66 million shares of Truking Technology Limited at a conversion ratio of 2.2083:1, and the unconverted share capital of RMB 79,746,802.21 was included in the Company's capital reserve. On October 27, 2010, the Company obtained the "Business License of Enterprise Legal Person" (Registration No. 430124000003013) issued by the Changsha Administration for Industry and Commerce, with registered capital and paid-in capital of RMB 66 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Changsha Truking Investment Group Co., Ltd. General Legal Person 22470.66 38.99
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 938.65 1.63
3 Anxin Pharmaceutical Health Theme Equity Fund (Class A) Fund 173.38 0.30
4 Nord Small and Medium Cap Mixed Securities Investment Fund Fund 20.00 0.03
5 China Merchants Huazheng Value Select 50 Index Fund (Class A) Fund 3.58 0.01

5. Concept Sectors

  • High-end Equipment
  • Intelligent Machinery
  • Immunotherapy
  • Intelligent Healthcare
  • Artificial Intelligence
  • Synthetic Biology
  • AI Agent
  • DeepSeek
  • Margin Trading and Securities Lending

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information